Join us in the second episode of BIOCast as Dr. Kevin Heist and Dr. Ulrika Birgersdotter-Green—two of the world’s leading electrophysiologists—dive into the critical factors that shape the choice of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).

Together, they break down how device selection impacts patient outcomes, explore the evolving role of new technologies, and share real-world insights from their extensive clinical experience. Whether you’re a practicing electrophysiologist, a fellow in training, or part of the broader healthcare community, this discussion offers practical perspectives and valuable considerations for tailoring device therapy to each patient’s unique needs.

Tune in to learn what drives device choice today—and how the right ICD or CRT-D can transform patient care.

In this inaugural episode of BIOCast, Dr. David Hayes sits down with nationally known electrophysiologist Dr. Kevin Campbell to explore how AI-driven algorithms are transforming the efficiency of implantable cardiac monitors (ICMs). With increasing demands on clinics and healthcare professionals, reducing workload while maintaining high-quality patient care is more critical than ever.

Dr. Campbell, a board-certified electrophysiologist who has held a variety of academic and industry leadership roles and is now with Health First Heart and Vascular in Melbourne, Florida, shares insights on how next-generation AI algorithms can filter out false detections, streamline clinical workflows, and enhance decision-making. Join us for this important discussion on how technology is reshaping the future of remote cardiac monitoring—allowing clinicians to focus on what truly matters: patient care.